Home / France / Phaxiam Therapeutics
Phaxiam Therapeutics
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
66 disclosures on record
Evolution of the disclosed total
0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
March 31, 2015 today
Open positions
No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| December 16, 2021 | Voleon Capital Management LP | 0.48% | December 20, 2021 |
| October 11, 2021 | Voleon Capital Management LP | 0.53% | December 20, 2021 |
| May 18, 2021 | Voleon Capital Management LP | 0.49% | May 20, 2021 |
| May 13, 2021 | Voleon Capital Management LP | 0.57% | May 20, 2021 |
| May 10, 2021 | Voleon Capital Management LP | 0.67% | May 20, 2021 |
| April 22, 2021 | Voleon Capital Management LP | 0.80% | May 20, 2021 |
| April 16, 2021 | Voleon Capital Management LP | 0.71% | May 20, 2021 |
| April 13, 2021 | Voleon Capital Management LP | 0.61% | May 20, 2021 |
| April 8, 2021 | Voleon Capital Management LP | 0.50% | May 20, 2021 |
| March 15, 2021 | Voleon Capital Management LP | 0.49% | March 23, 2021 |
| March 11, 2021 | Voleon Capital Management LP | 0.57% | March 23, 2021 |
| March 9, 2021 | Voleon Capital Management LP | 0.65% | March 23, 2021 |
| March 4, 2021 | Voleon Capital Management LP | 0.70% | March 23, 2021 |
| February 24, 2021 | Voleon Capital Management LP | 0.69% | March 23, 2021 |
| February 23, 2021 | Voleon Capital Management LP | 0.70% | March 23, 2021 |
| February 17, 2021 | Voleon Capital Management LP | 0.62% | March 23, 2021 |
| February 12, 2021 | Voleon Capital Management LP | 0.52% | March 23, 2021 |
| January 8, 2018 | GSA Capital Partners LLP | 0.48% | January 10, 2018 |
| January 5, 2018 | GSA Capital Partners LLP | 0.53% | January 10, 2018 |
| December 15, 2017 | GSA Capital Partners LLP | 0.68% | January 10, 2018 |
| December 14, 2017 | GSA Capital Partners LLP | 0.70% | January 10, 2018 |
| December 11, 2017 | GSA Capital Partners LLP | 0.68% | January 10, 2018 |
| December 6, 2017 | GSA Capital Partners LLP | 0.50% | January 10, 2018 |
| November 14, 2017 | GSA Capital Partners LLP | 0.35% | November 16, 2017 |
| November 10, 2017 | GSA Capital Partners LLP | 0.50% | November 16, 2017 |
| November 3, 2016 | GSA Capital Partners LLP | 0.49% | November 7, 2016 |
| September 12, 2016 | GSA Capital Partners LLP | 0.50% | November 7, 2016 |
| August 4, 2016 | GSA Capital Partners LLP | 0.49% | August 8, 2016 |
| July 7, 2016 | GSA Capital Partners LLP | 0.59% | August 8, 2016 |
| June 22, 2016 | GSA Capital Partners LLP | 0.69% | August 8, 2016 |
| June 9, 2016 | GSA Capital Partners LLP | 0.79% | August 8, 2016 |
| May 31, 2016 | GSA Capital Partners LLP | 0.87% | August 8, 2016 |
| May 24, 2016 | GSA Capital Partners LLP | 0.98% | August 8, 2016 |
| May 12, 2016 | GSA Capital Partners LLP | 1.09% | August 8, 2016 |
| May 4, 2016 | GSA Capital Partners LLP | 1.19% | August 8, 2016 |
| April 26, 2016 | GSA Capital Partners LLP | 1.29% | August 8, 2016 |
| April 20, 2016 | GSA Capital Partners LLP | 1.38% | August 8, 2016 |
| April 14, 2016 | GSA Capital Partners LLP | 1.49% | August 8, 2016 |
| April 11, 2016 | GSA Capital Partners LLP | 1.58% | August 8, 2016 |
| April 5, 2016 | GSA Capital Partners LLP | 1.69% | August 8, 2016 |
| March 17, 2016 | GSA Capital Partners LLP | 1.79% | August 8, 2016 |
| March 9, 2016 | GSA Capital Partners LLP | 1.80% | August 8, 2016 |
| March 2, 2016 | GSA Capital Partners LLP | 1.73% | August 8, 2016 |
| February 17, 2016 | GSA Capital Partners LLP | 1.61% | August 8, 2016 |
| February 8, 2016 | GSA Capital Partners LLP | 1.50% | August 8, 2016 |
| January 7, 2016 | GSA Capital Partners LLP | 1.49% | August 8, 2016 |
| December 18, 2015 | GSA Capital Partners LLP | 1.59% | August 8, 2016 |
| December 16, 2015 | GSA Capital Partners LLP | 1.60% | August 8, 2016 |
| December 8, 2015 | GSA Capital Partners LLP | 1.51% | August 8, 2016 |
| November 23, 2015 | GSA Capital Partners LLP | 1.70% | August 8, 2016 |
Other companies sold short in France
- Ubisoft Entertainment 13.69% of the capital sold short
- Valeo 10.92% of the capital sold short
- Teleperformance 8.94% of the capital sold short
- FDJ United 6.67% of the capital sold short
- Renault 6.54% of the capital sold short
- Remy Cointreau 5.36% of the capital sold short
- Viridien 5.32% of the capital sold short
- Alstom 5.23% of the capital sold short
- Abivax 5.04% of the capital sold short
- Worldline 4.48% of the capital sold short
- Vusiongroup 4.08% of the capital sold short
- Forvia 4.06% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Phaxiam Therapeutics, source AMF, data as at December 16, 2021, https://www.quivad.com/action/phaxiam-therapeutics